l-Theanine healed NSAID-induced gastric ulcer by modulating pro/antioxidant balance in gastric ulcer margin
Abstract l-Theanine is a unique non-protein-forming amino acid present in tea [Camellia sinensis (L.) O. Kuntze]. In the present work, we evaluated the healing effect of l-theanine on NSAID (indomethacin)-induced gastric ulcer. Histology of the stomach tissues revealed maximum ulceration on the third day after indomethacin administration (18 mg/kg, single dose p.o.) which was accompanied by increased lipid peroxidation; protein carbonylation; Th1 cytokine synthesis, and depletion of thiol, mucin, prostaglandin (PG) E, Th2 cytokine synthesis; and total antioxidant status in mice. l-Theanine healed gastric ulcer at a dose of 10 mg/kg b.w. but aggravated the ulcerated condition at a higher dose of 40 mg/kg b.w. At 10 mg/kg b.w., l-theanine significantly alleviated the adverse oxidative effect of indomethacin through enhanced synthesis of $ PGE_{2} $ by modulation of cyclo-oxygenase-1 and 2 [COX-1 and COX-2] expression, Th1/Th2 cytokine balance, and restoration of cellular antioxidant status at the gastric ulcer margin. The present study revealed for the first time the dose-dependent biphasic effect of a natural neuroprotective agent, l-theanine, on gastric ulcer disease..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2014 |
---|---|
Erschienen: |
2014 |
Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
---|---|
Enthalten in: |
Journal of natural medicines - 68(2014), 4 vom: 01. Juli, Seite 699-708 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chatterjee, Sirshendu [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
-Theanine |
doi: |
10.1007/s11418-014-0852-x |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR019070829 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR019070829 | ||
003 | DE-627 | ||
005 | 20230519224012.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201006s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11418-014-0852-x |2 doi | |
035 | |a (DE-627)SPR019070829 | ||
035 | |a (SPR)s11418-014-0852-x-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.41 |2 bkl | ||
084 | |a 44.98 |2 bkl | ||
100 | 1 | |a Chatterjee, Sirshendu |e verfasserin |4 aut | |
245 | 1 | 0 | |a l-Theanine healed NSAID-induced gastric ulcer by modulating pro/antioxidant balance in gastric ulcer margin |
264 | 1 | |c 2014 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract l-Theanine is a unique non-protein-forming amino acid present in tea [Camellia sinensis (L.) O. Kuntze]. In the present work, we evaluated the healing effect of l-theanine on NSAID (indomethacin)-induced gastric ulcer. Histology of the stomach tissues revealed maximum ulceration on the third day after indomethacin administration (18 mg/kg, single dose p.o.) which was accompanied by increased lipid peroxidation; protein carbonylation; Th1 cytokine synthesis, and depletion of thiol, mucin, prostaglandin (PG) E, Th2 cytokine synthesis; and total antioxidant status in mice. l-Theanine healed gastric ulcer at a dose of 10 mg/kg b.w. but aggravated the ulcerated condition at a higher dose of 40 mg/kg b.w. At 10 mg/kg b.w., l-theanine significantly alleviated the adverse oxidative effect of indomethacin through enhanced synthesis of $ PGE_{2} $ by modulation of cyclo-oxygenase-1 and 2 [COX-1 and COX-2] expression, Th1/Th2 cytokine balance, and restoration of cellular antioxidant status at the gastric ulcer margin. The present study revealed for the first time the dose-dependent biphasic effect of a natural neuroprotective agent, l-theanine, on gastric ulcer disease. | ||
650 | 4 | |a Antioxidant |7 (dpeaa)DE-He213 | |
650 | 4 | |a COX |7 (dpeaa)DE-He213 | |
650 | 4 | |a Cytokines |7 (dpeaa)DE-He213 | |
650 | 4 | |a Gastric ulcer |7 (dpeaa)DE-He213 | |
650 | 4 | |a Indomethacin |7 (dpeaa)DE-He213 | |
650 | 4 | |a -Theanine |7 (dpeaa)DE-He213 | |
650 | 4 | |a NSAID |7 (dpeaa)DE-He213 | |
700 | 1 | |a Chatterjee, Ananya |e verfasserin |4 aut | |
700 | 1 | |a Roy, Surmi |e verfasserin |4 aut | |
700 | 1 | |a Bera, Biswajit |e verfasserin |4 aut | |
700 | 1 | |a Bandyopadhyay, Sandip K. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of natural medicines |d Tokyo : Springer, 2006 |g 68(2014), 4 vom: 01. Juli, Seite 699-708 |w (DE-627)SPR019061757 |w (DE-600)2218478-8 |x 1861-0293 |7 nnns |
773 | 1 | 8 | |g volume:68 |g year:2014 |g number:4 |g day:01 |g month:07 |g pages:699-708 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11418-014-0852-x |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-ASE | ||
936 | b | k | |a 44.41 |q ASE |
936 | b | k | |a 44.98 |q ASE |
951 | |a AR | ||
952 | |d 68 |j 2014 |e 4 |b 01 |c 07 |h 699-708 |